MK-0873 Terminated Phase 2 Trials for Chronic Obstructive Pulmonary Disease (COPD) / Lung Disorder Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00132730
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)